Walleye Capital’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.63M | Sell |
66,482
-28,508
| -30% | -$1.13M | 0.01% | 553 |
|
|
2025
Q1 | $2.87M | Buy |
94,990
+78,735
| +484% | +$2.38M | 0.01% | 513 |
|
|
2024
Q4 | $568K | Sell |
16,255
-107,861
| -87% | -$3.77M | ﹤0.01% | 1119 |
|
|
2024
Q3 | $4.97M | Buy |
124,116
+26,245
| +27% | +$1.05M | 0.01% | 444 |
|
|
2024
Q2 | $4.66M | Buy |
97,871
+8,741
| +10% | +$417K | 0.01% | 491 |
|
|
2024
Q1 | $3.86M | Buy |
+89,130
| New | +$3.86M | 0.01% | 537 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 2554 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 2607 |
|
|
2023
Q2 | – | Sell |
-2,240
| Closed | -$80.1K | – | 2447 |
|
|
2023
Q1 | $80.1K | Sell |
2,240
-23,814
| -91% | -$851K | ﹤0.01% | 1543 |
|
|
2022
Q4 | $984K | Sell |
26,054
-59,909
| -70% | -$2.26M | 0.02% | 731 |
|
|
2022
Q3 | $3.8M | Buy |
85,963
+79,594
| +1,250% | +$3.52M | 0.07% | 267 |
|
|
2022
Q2 | $236K | Buy |
+6,369
| New | +$236K | 0.01% | 1409 |
|
|
2021
Q4 | – | Sell |
-15,470
| Closed | -$519 | – | 2135 |
|
|
2021
Q3 | $519 | Buy |
+15,470
| New | +$519 | 0.01% | 753 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 734 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 864 |
|
|
2019
Q3 | – | Sell |
-170
| Closed | -$11K | – | 731 |
|
|
2019
Q2 | $11K | Sell |
170
-1,490
| -90% | -$96.4K | ﹤0.01% | 425 |
|
|
2019
Q1 | $135K | Buy |
+1,660
| New | +$135K | 0.02% | 111 |
|